CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 38 enrolled
Drug / intervention
Propranolol +3 moredrug
Likely dose
Propranolol 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02032758
NCT02032758Phase 4Completed
CompareCT.gov

Golfer's Cramp: Correlation of Wrist Movements and Surface EMG With Putter Movements

Mayo Clinic·interventional·Posted Jan 10, 2014·Updated Jul 25, 2016

In Brief

A Phase 4 clinical trial evaluating Propranolol, Opal Device, and 2 other interventions for Occupational; Cramp(s). Completed, enrolled 38 participants across 1 site.

Detailed Summary

The investigators will investigate golfers with visual evidence of an involuntary movement while putting before and after treatment with a low dose of propranolol.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOccupational; Cramp(s)
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 10, 2014
Enrollment StartJan 1, 2014
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 12.5 years ago

Interventions

Propranololdrug

Single oral dose of 10 mg propranolol

Opal Devicedevice

The Opal Device (APDM, Inc.) will be used to measure wrist movement.

Science and Motion PuttLab (SAM)procedure

The SAM will be used to study putter stroke movement and ball movement.

Surface Electromyography EMGdevice

The surface EMG will be used to evaluate co-contraction of the wrist flexor/extensor muscle groups and the wrist pronator/supinator muscle groups.